We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Millennium Pharmaceuticals (MM) | NASDAQ:MLNM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.97 | 0 | 01:00:00 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Expires: January 31, 2008 Estimated average burden hours per response... 0.5 |
|
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person
*
Fanucci Marsha |
2. Issuer Name
and
Ticker or Trading Symbol
MILLENNIUM PHARMACEUTICALS INC [ MLNM ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) SVP, Chief Financial Officer |
MILLENNIUM PHARMACEUTICALS, INC., 40 LANDSDOWNE STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
CAMBRIDGE, MA 02139 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 5/14/2008 | D | 109514 (1) | D | $25.00 | 0 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee stock option (right to buy) | $16.13 | 5/14/2008 | D | 6019 | (2) | 9/26/2011 | Common Stock | 6019 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $19.49 | 5/14/2008 | D | 13164 | (2) | 2/27/2012 | Common Stock | 13164 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $22.04 | 5/14/2008 | D | 13164 | (2) | 3/27/2012 | Common Stock | 13164 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $18.42 | 5/14/2008 | D | 6855 | (2) | 4/26/2012 | Common Stock | 6855 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $7.99 | 5/14/2008 | D | 2988 | (2) | 10/17/2012 | Common Stock | 2988 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $8.27 | 5/14/2008 | D | 2988 | (2) | 11/15/2012 | Common Stock | 2988 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $9.35 | 5/14/2008 | D | 2987 | (2) | 12/17/2012 | Common Stock | 2987 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $6.88 | 5/14/2008 | D | 19271 | (2) | 2/26/2013 | Common Stock | 19271 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $12.57 | 5/14/2008 | D | 7119 | (2) | 7/31/2013 | Common Stock | 7119 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $13.91 | 5/14/2008 | D | 7118 | (2) | 8/29/2013 | Common Stock | 7118 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $14.68 | 5/14/2008 | D | 19272 | (2) | 9/2/2013 | Common Stock | 19272 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $15.45 | 5/14/2008 | D | 7118 | (2) | 9/30/2013 | Common Stock | 7118 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $15.92 | 5/14/2008 | D | 7813 | (2) | 10/31/2013 | Common Stock | 7813 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $15.83 | 5/14/2008 | D | 7812 | (2) | 11/28/2013 | Common Stock | 7812 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $18.65 | 5/14/2008 | D | 7812 | (2) | 12/31/2013 | Common Stock | 7812 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $17.77 | 5/14/2008 | D | 37500 | (2) | 2/25/2014 | Common Stock | 37500 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $11.15 | 5/14/2008 | D | 25000 | (2) | 7/28/2014 | Common Stock | 25000 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $11.89 | 5/14/2008 | D | 25000 | (2) | 8/31/2014 | Common Stock | 25000 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $12.09 | 5/14/2008 | D | 37500 | (2) | 9/1/2014 | Common Stock | 37500 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $13.36 | 5/14/2008 | D | 125000 | (2) | 9/23/2014 | Common Stock | 125000 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $13.67 | 5/14/2008 | D | 25000 | (2) | 9/30/2014 | Common Stock | 25000 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $8.41 | 5/14/2008 | D | 212500 | (2) | 3/3/2015 | Common Stock | 212500 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $10.84 | 5/14/2008 | D | 45000 | (2) | 2/27/2017 | Common Stock | 45000 | $0 | 0 | D | ||||
Employee stock option (right to buy) | $13.90 | 5/14/2008 | D | 68395 | (2) | 2/14/2008 | Common Stock | 68395 | $0 | 0 | D |
Explanation of Responses: | |
( 1) | Reflects shares of restricted stock that were exchanged for a cash payment of $25.00 per share in connection with the merger (the "Merger") of Mahogany Acquisition Corp. with and into Millennium Pharmaceuticals, Inc. |
( 2) | This option was cancelled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price and $25.00. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Fanucci Marsha
MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE, MA 02139 |
|
|
SVP, Chief Financial Officer |
|
Signatures
|
||
Joel S. Goldberg, Attorney-In-Fact | 5/15/2008 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Millennium Pharmaceuticals (MM) Chart |
1 Month Millennium Pharmaceuticals (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions